| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |